跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,596 条关于
“Cloudbreak Pharma”
全部
9,596
临床试验
4,079
药物
1,114
机构
1,221
资讯
3,182
去年
Cloudbreak Pharma's CBT-004 Achieves Primary Endpoint in Phase 2 Trial for Vascularized Pinguecula
9个月前
Cloudbreak Therapeutics Advances CBT-004 to Phase 3 Trials Following Successful FDA Meeting for Vascularized Pinguecula Treatment
3个月前
CLOUDBREAK-B Receives FDA Clearance for CBT-199 Ophthalmic Drug Trial and Submits IND for Dry Eye Candidate CBT-358
去年
Cidara's CD388 Shows Promise as Universal Influenza Preventative in Nature Microbiology Publication
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
去年
FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance
去年
Cidara Therapeutics Completes Enrollment in Phase IIb Trial of CD388 for Influenza Prevention
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
上个月
Fierce Pharma Week Europe Launches in Basel for 2027, Targeting Cross-Functional Pharma Leadership
第 1 页,共 319 页
上一页
下一页